Vijaya Gunjal

1PUBLICATIONS
1CO-AUTHORS
Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 23, 2025
Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer.

Kumar Prabhash, Roshan Pawar, Vijaya Gunjal

Pageof 1

Frequent Collaborators

1 joint publications

Kumar Prabhash